| VIVIX | VRVIX | VIVIX / VRVIX | |
| Total Expense Ratio | 0.03 | 0.05 | 60% |
| Annual Report Gross Expense Ratio | 0.03 | 0.05 | 60% |
| Fund Existence | 28 years | 16 years | - |
| Gain YTD | 15.125 | 19.721 | 77% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 5000000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 254B | 21.5B | 1,181% |
| Annual Yield % from dividends | 1.86 | 1.56 | 119% |
| Returns for 1 year | 24.28 | 28.97 | 84% |
| Returns for 3 years | 50.26 | 55.16 | 91% |
| Returns for 5 years | 58.89 | 58.08 | 101% |
| Returns for 10 years | 154.95 | 143.47 | 108% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| WPSIX | 50.46 | 0.91 | +1.84% |
| AB Concentrated Growth I | |||
| PABGX | 198.35 | 3.00 | +1.54% |
| T. Rowe Price Blue Chip Growth Advisor | |||
| PCAQX | 92.01 | 0.39 | +0.43% |
| Principal Capital Appreciation R5 | |||
| SAMVX | 13.17 | 0.03 | +0.23% |
| Virtus Ceredex Mid-Cap Value Equity A | |||
| KMDVX | 34.84 | -0.01 | -0.03% |
| Keeley Gabelli Mid Cap Dividend A | |||